The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
Discover how Moleculin Biotech advances Annamycin's Phase 3 trial for AML treatment, with key milestones planned through 2025.
Clinical Trials Arena on MSN18h
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatmentImunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.
X4 Pharmaceuticals highlights 2024 as transformative with XOLREMDI's U.S. launch, international expansion, & Phase 3 trial progress.
The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback